Do statins lower testosterone and does it matter?

BMC Medicine

George Thanassoulis¹  Allan D Sniderman¹ 

[1] Division of Cardiology, McGill University Health Centre, 687 Pine Avenue West, Montreal, QC H3A 1A1, Canada

关键词: drug side effects;    testosterone;    statins;   

Others  :  857163
DOI  :  10.1186/1741-7015-11-58

 received in 2013-02-12, accepted in 2013-02-28,  发布年份 2013

【 摘 要 】

Drugs are two-sided swords and statins are no exception. Schooling et al. demonstrate that, on average, statins produce small, but statistically significant, decreases in testosterone. They appropriately emphasize that the clinical significance of their observations is unclear but suggest that changes in testosterone might be related to the benefits of therapy as well as the risks, such as the increased chance of diabetes mellitus. Their findings and hypotheses are noteworthy. However, we believe this represents another example of the limitations in the published summaries of drug effects. How do we know all changes induced by drugs are normally distributed? Some may be affected much more than others. Moreover, the confidence intervals of a meta-analysis describe the variance of the mean effect, not the range of effects, and while the mean change characterizes the impact of a drug on a group of patients, the range more fully characterizes its effects on individuals. We treat individuals not groups. Averages do not disclose enough about the risks and benefits of drugs.

See related research article here http://www.biomedcentral.com/1741-7015/11/57 webcite

【 授权许可】

   
2013 Sniderman and Thanassoulis; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Ridker PM, Pradhan A, MacFadyen JG, Libby P, Glynn RJ: Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet 2012, 380:565-571.
• [2]Schooling CM, Yeung SLA, Freeman G, Cowling BJ: The effect of statins on testosterone in men and women, a systematic review and meta-analysis of randomized controlled trials. BMC Med 2013, 11:57.
• [3]de Graaf L, Brouwers AH, Diemont WL: Is decreased libido associated with the use of HMG-Co-A-reductase inhibitors? Br J Clin Pharmacol 2004, 58:326-328.
• [4]Do C, Huyghe E, Lapeyre-Mestre M, Montastruc JL, Bagheri H: Statins and erectile dysfunction: results of a case/non-case study using the French Pharmacovigilance System Database. Drug Saf 2009, 32:591-597.
• [5]Awan Z, Seidah NG, MacFadyen JG, Benjannet S, Chasman DI, Ridker PM, Genest J: Rosuvastatin, proprotein convertase subtilisin/kexin type 9 concentrations, and LDL cholesterol response: the JUPITER trial. Clin Chem 2010, 58:183-189.
• [6]Cholesterol Treatment Trialists'(CTT) Collaboration, Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, Collins R: Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomized trials. Lancet 2010, 376:1670-1681.